
Recro Strengthens Leadership Team With Key Executive and Board Appointments
MALVERN, PA — Recro Pharma, Inc. (NASDAQ: REPH), a dedicated contract development and manufacturing organization (CDMO) solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products, …
Read More